Potential of gene therapy for the treatment of pituitary tumors. ;

GOYA RG ,; SARKAR DK ,; BROWN OA; HEREÑÚ CB

CURRENT GENE THERAPY

Bentham Science Publishers

Lugar: Karachi; Año: 2004 vol. 1 p. 79 - 79

1566-5232

p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none">Abstract: Pituitary adenomas constitute the most frequent neuroendocrine pathology, comprising up to 15% of primary intracranial tumors. Current therapies for pituitary tumors include surgery and radiotherapy, as well as pharmacological approaches for some types. Although all of these approaches have shown a significant degree of success, they are not devoid of unwanted side effects,